TUMOUR MARKERS CONFERENCE

7 February 2018

5.25 CME Points

Za’abeel Hall 6, Conference Room 2

Overview

The Tumour Markers Conference deals with advances in biomarkers used in oncology to help detect the presence of cancer. This an extraordinary event is designed to gather oncologists and lab professionals to better understand application of research findings related to Cancer.

Key Topics:

  • Tumour Markers associated with Cell Proliferation
  • Tumour Markers related to Cell Differentiation
  • Tumor Markers related to Metastasis
  • Clinical applications of tumour markers
  • Recommendations for ordering tumour marker tests
  • State-of-the-art diagnostics for personalised medicine

Benefits of attending:

  • Discuss advances in pathophysiology to improve skills on identification or accuracy in testing
  • Review the role of tumour markers in clinical practice
  • Identify pitfalls in interpreting results

Chair: Dr Mohanad Diab, Head, Medical Oncology, NMC Specialty Hospital, Abu Dhabi, UAE

 

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics | Beckman Coulter | Siemens Healthineers

Supported by:

Cleveland Clinic Foundation Centre for Continuing Education acknowledges educational grants for partial support of this activity from: 
Abbott Diagnostics
Beckman Coulter
Siemens Healthineers

09:50

Opening remarks by the chair

Dr Mohanad Diab, Head, Medical Oncology, NMC Specialty Hospital, Abu Dhabi, UAE

Session 1

10:00

Tumour markers in clinical practice and in the laboratory

Dr Mohanad Diab, Head, Medical Oncology, NMC Specialty Hospital, Abu Dhabi, UAE

10:30

The role of PD-L1 and microsatellite testing for management with immunotherapy

Dr Bassam Estfan, Gastrointestinal Oncology, Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA

11:00 Coffee Break


Session 2

11:30

Clinical applications of tumour markers in radiation oncology

Dr Daniel Tan, Medical Director and Consultant Radiation Oncologist, Asian American Radiation Oncology, Gleneagles Hospital, Singapore

12:00

Tumour markers predictive and prognostic in breast cancers

Dr Sreekala Sreehari, Specialist Histopathology, NMC Royal Hospital, Abu Dhabi, UAE

12:30

Liquid biopsy – introduction and overview

Dr Basel Altrabulsi, Chief Medical Officer, National Reference Laboratory, Abu Dhabi, UAE

13:00 Lunch Break


Session 3

14:00

Progress with biomarkers in colorectal cancer

Dr Elizabeth Wagar, Chair, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

14:45

Immunoscore as a prognostic and predictive biomarker in cancer

Dr Martine Mc Mannus, Consultant Anatomic Pathologist, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

15:30 Coffee Break


Session 4

16:00

Tumour markers in lung cancer

Prof Keith Kerr, Consultant Pathologist, University of Aberdeen, Aberdeen, Scotland

16:30

PD-L1 in lung cancer

Dr Hassan Jaafar, Medical Consultant, Tawam Hospital, Al Ain, UAE

17:00 End of conference

Supported by:

ACTIVITY DIRECTORS:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Lab Med Institute, Cleveland Clinic, Cleveland, Ohio, USA


PLANNING COMMITTEE:

Dr Mohanad Diab, Head, Medical Oncology, NMC Specialty Hospital, Abu Dhabi, UAE


SPEAKER FACULTY:

Dr Basel Altrabulsi, Chief Medical Officer, National Reference Laboratory, Abu Dhabi, UAE

Dr Bassam Estfan, Gastrointestinal Oncology, Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA

Dr Daniel Tan, Medical Director and Consultant Radiation Oncologist, Asian American Radiation Oncology, Gleneagles Hospital, Singapore

Dr Elizabeth Wagar, Chair,  Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Dr Hassan Jaafar, Medical Consultant, Tawam Hospital, Al Ain, UAE

Prof Keith Kerr, Consultant Pathologist, University of Aberdeen, Aberdeen, Scotland

Dr Martine Mc Mannus, Consultant Anatomic Pathologist, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Sreekala Sreehari, Specialist Histopathology, NMC Royal Hospital, Abu Dhabi, UAE

Supported by: